Analyst Ratings for Thoratec (THOR) [Buys]
THOR Rating Summary
THOR Price Target Summary
- Highest: $50.00 (ThinkEquity)
- Lowest: $31.00 (Wedbush)
- Average: $38.71
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$38.71 (+23.3%)
Avg. $ Target:
$38.71 (+23.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2013 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
35.74 | 31.39 | -12.17% | Details |
| 11/21/2012 | Wells Fargo | Upgrade | Outperform (Market Perform) |
41.50 (34.50) |
35.00 | 31.39 | -10.31% | Details |
| 10/3/2012 | UBS | Upgrade | Buy (Neutral) |
39.00 (35.00) |
34.29 | 31.39 | -8.46% | Details |
| 2/9/2012 | Piper Jaffray | Upgrade | Overweight (N/A) |
37.00 (N/A) |
30.81 | 31.39 | 1.88% | Details |
| 2/3/2012 | ThinkEquity | New Coverage | Buy (N/A) |
50.00 (N/A) |
30.76 | 31.39 | 2.05% | Details |
| 5/18/2011 | Oppenheimer | New Coverage | Outperform (N/A) |
N/A (N/A) |
33.09 | 31.39 | -5.14% | Details |
| 4/18/2011 | Leerink Swann | Upgrade | Outperform (N/A) |
N/A (N/A) |
31.51 | 31.39 | -0.38% | Details |
| 12/7/2010 | Boenning & Scattergood | New Coverage | Outperform (N/A) |
N/A (N/A) |
25.67 | 31.39 | 22.28% | Details |
| 12/1/2010 | Weeden & Co | New Coverage | Buy (N/A) |
N/A (N/A) |
25.43 | 31.39 | 23.44% | Details |
| 11/19/2010 | Barclays » Updated 5/12/2011 |
Upgrade | Overweight (N/A) |
N/A (N/A) |
26.10 | 31.39 | 20.27% | Details |
| 11/1/2010 | Rodman & Renshaw | Upgrade | Market Outperform (N/A) |
N/A (N/A) |
32.66 | 31.39 | -3.89% | Details |
| 8/24/2010 | Madison Williams | New Coverage | Buy (N/A) |
N/A (N/A) |
33.79 | 31.39 | -7.1% | Details |
